◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
WAKAMOTO PHARMACEUTICAL CO.,LTD. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemQ4 2025Nov 13, 2025Q4 2024Nov 13, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
+Operating Income -276.7M -328.4M -- -- -- --
Operating Margin % 107.9% 102.7% -- -- -- --
+Ordinary Income -256.4M -319.8M -- -- -- --
Revenue Growth % 19.8% -- -- -- -- --
Line ItemQ4 2025Nov 13, 2025Q4 2024Nov 13, 2024Q1 2024Mar 31, 2024Q1 2023Mar 31, 2023Q1 2022Mar 31, 2022Q1 2021Mar 31, 2021
Current Assets 8.9B 9.0B -- -- -- --
Total Assets 15.0B 15.4B 15.3B 14.8B 14.7B 14.6B
Current Liabilities 2.0B 1.8B -- -- -- --
Total Liabilities 3.4B 3.4B 3.6B 3.3B 3.4B 3.2B
Total Equity 11.6B 12.0B 11.7B 11.5B 11.3B 11.3B
Equity Ratio -- -- 0.77 0.78 0.77 0.78
No data available for this statement.
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...